Clinical Trial Update: A Phase 1 Study of BST02 in Treating Locally Advanced Liver Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for BST02 targeting locally advanced hepatocellular carcinoma (liver cancer).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• BST02

Snippet

Sponsor: BioSyngen Pte Ltd | Conditions: Locally Advanced Liver Carcinoma | Phase 1 | Status: UNKNOWN